Show simple item record

dc.rights.licenseopenen_US
hal.structure.identifierNutrition et Neurobiologie intégrée [NutriNeuro]
dc.contributor.authorDI MICELI, Mathieu
hal.structure.identifierNutrition et Neurobiologie intégrée [NutriNeuro]
dc.contributor.authorBOSCH BOUJU, Clementine
ORCID: 0000-0001-8869-768X
IDREF: 156530244
hal.structure.identifierNutrition et Neurobiologie intégrée [NutriNeuro]
dc.contributor.authorLAYE, Sophie
ORCID: 0000-0002-3843-1012
IDREF: 11366883X
dc.date.accessioned2021-09-22T14:20:17Z
dc.date.available2021-09-22T14:20:17Z
dc.date.issued2020-11
dc.identifier.issn0029-6651en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/112333
dc.description.abstractEnPUFA of the n-3 and n-6 families are present in high concentration in the brain where they are major components of cell membranes. The main forms found in the brain are DHA (22 :6, n-3) and arachidonic acid (20:4, n-6). In the past century, several studies pinpointed that modifications of n-3 and n-6 PUFA levels in the brain through dietary supply or genetic means are linked to the alterations of synaptic function. Yet, synaptopathies emerge as a common characteristic of neurodevelopmental disorders, neuropsychiatric diseases and some neurodegenerative diseases. Understanding the mechanisms of action underlying the activity of PUFA at the level of synapses is thus of high interest. In this frame, dietary supplementation in PUFA aiming at restoring or promoting the optimal function of synapses appears as a promising strategy to treat synaptopathies. This paper reviews the link between dietary PUFA, synapse formation and the role of PUFA and their metabolites in synaptic functions.
dc.language.isoENen_US
dc.subject.enSynaptic plasticity
dc.subject.enDHA
dc.subject.enEPA
dc.subject.enEndocannabinoids
dc.subject.enOxylipins
dc.subject.enAnandamide
dc.subject.enArachidonic acid
dc.subject.enCannabinoid receptor 1
dc.subject.enCannabinoid receptor 2
dc.subject.enCyclooxygenase 1. 2
dc.subject.enN-docosahexaenoylethanolamide
dc.subject.enEndocannabinoids
dc.subject.enY aminobutyric acid
dc.subject.enG protein-coupled receptor
dc.subject.enLinoleic acid
dc.subject.enLong-chain
dc.subject.enLong-term depression
dc.subject.enLong-term potentiation
dc.subject.enPlatelet-activating factor
dc.subject.enPhospholipase A2
dc.title.enPUFA and their derivatives in neurotransmission and synapses: a new hallmark of synaptopathies
dc.typeArticle de revueen_US
dc.identifier.doi10.1017/S0029665120000129en_US
dc.subject.halSciences du Vivant [q-bio]/Neurosciences [q-bio.NC]en_US
dc.identifier.pubmed32299516en_US
bordeaux.journalProceedings of the Nutrition Societyen_US
bordeaux.page388-403en_US
bordeaux.volume79en_US
bordeaux.hal.laboratoriesNutriNeurO (Laboratoire de Nutrition et Neurobiologie Intégrée) - UMR 1286en_US
bordeaux.issue4en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINRAEen_US
bordeaux.teamPsychoneuroimmunologie et Nutrition: Approches expérimentales et cliniquesen_US
bordeaux.teamNutrition, mémoire et glucocorticoïdesen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.exportfalse
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Proceedings%20of%20the%20Nutrition%20Society&rft.date=2020-11&rft.volume=79&rft.issue=4&rft.spage=388-403&rft.epage=388-403&rft.eissn=0029-6651&rft.issn=0029-6651&rft.au=DI%20MICELI,%20Mathieu&BOSCH%20BOUJU,%20Clementine&LAYE,%20Sophie&rft.genre=article


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record